Eckuity is a venture capital firm established in 2021 and headquartered in New York, New York. The firm specializes in strategic investments that aim to transform innovative scientific advancements into future healthcare solutions. Eckuity focuses on various sectors, including business-to-consumer markets, healthcare, information technology, 3D printing, artificial intelligence, digital health, health technology, the Internet of Things, life sciences, and robotics. Its investment strategy targets opportunities across the United States, Europe, and Asia, positioning Eckuity as a key player in advancing healthcare technologies and related fields. As a Registered Investment Adviser, the firm is committed to fostering growth in industries that enhance human health and well-being.
Ansella Therapeutics is a pharmaceutical company dedicated to developing innovative treatments for women's health, particularly addressing various vaginal health conditions. The firm focuses on creating both over-the-counter and prescription products aimed at enhancing vaginal health across different life stages. One of its key offerings includes a lubricant that utilizes cholesterol and fatty acids to support favorable cellular properties in the vaginal epithelium, thereby enabling more effective treatment of vaginal issues. Through its specialized approach, Ansella Therapeutics aims to improve healthcare solutions for women.
Avive
Venture Round in 2024
Avive Solutions is a company that develops an advanced Automated External Defibrillator (AED) aimed at improving survival rates from sudden cardiac arrest (SCA). Their device is designed to be portable, affordable, and user-friendly, ensuring that anyone can effectively respond to an SCA incident. In addition to the AED, Avive offers a connected software platform that facilitates the transfer of critical incident data to emergency services and healthcare professionals, enhancing the overall response to cardiac emergencies. By addressing the challenges associated with SCA, Avive Solutions aims to empower individuals and organizations to save lives more effectively. The company is based in Brisbane, California.
Awak
Series B in 2023
AWAK Technologies Inc. is a medical technology company based in Singapore, founded in 2008, that specializes in the development of wearable dialysis devices aimed at managing end-stage renal disease. The company's flagship product, the Automated Wearable Artificial Kidney (AWAK), utilizes tidal peritoneal dialysis and innovative sorbent technology to regenerate used dialysis fluid, thereby enhancing the efficacy of treatment. Weighing less than 1 kg and powered by a battery, the device allows patients to maintain their daily routines without restrictions. AWAK Technologies has completed its research and development phase and is currently conducting clinical trials to secure FDA and CE certifications. The company has received ISO 13485 certification for its quality management system, underscoring its commitment to high standards in the design, manufacturing, and distribution of medical devices.
Sanoculis
Series C in 2023
Sanoculis is a medical device start-up based in Tel Aviv, Israel, focused on developing innovative solutions for glaucoma treatment. The company has created a Minimally Invasive Micro Sclerostomy (MIMS) procedure, which utilizes a single-patient-use sterile tool alongside a multi-use external machine. This technique involves the creation of a sclero-corneal drainage channel to effectively reduce intraocular pressure. MIMS is designed as a microfluidic full-thickness procedure, employing a cutting and drilling device to minimize trauma to surrounding tissue and decrease scar formation, ultimately facilitating the development of a long-lasting filtering bleb. Through this approach, Sanoculis aims to enhance outcomes for patients undergoing glaucoma surgery while reducing the risk of complications.
Sonrai Analytics
Venture Round in 2022
Sonrai Analytics develops an advanced analytics software platform aimed at enhancing data utilization for businesses in various sectors. Its platform leverages artificial intelligence and machine learning to enable predictive analytics, helping organizations discover new treatments and streamline research development. By addressing the challenges of precision analytics and reproducible data findings, Sonrai's solutions harness the vast amounts of data generated across successful business models. This approach allows companies to move away from outdated methods, facilitating the resolution of complex problems and the identification of competitive advantages in their respective markets.
Mobius Biomedical
Venture Round in 2022
Mobius Biomedical plans to bring unprecedented efficiencies to the development and manufacturing of biologics and biosimilars, and reduce their cost by over 90% at commercial scale. The Company has developed new design, new process and new equipment to drastically reduce the capex, opex and facility footprint of manufacturing plants while maintaining the purity, throughput and efficiency at commercial scale.
Professional Triathletes Organisation
Series B in 2022
Professional Triathletes Organisation is a nonprofit company that organizes events of the triathlon sport.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.